HEADER TRANSFERASE/TRANSFERASE INHIBITOR 30-NOV-12 4I6Q TITLE JAK3 KINASE DOMAIN IN COMPLEX WITH 2-PHENOXY-5H-PYRROLO[2,3- TITLE 2 B]PYRAZINE-7-CARBOXYLIC ACID ((S)-1-CYCLOPROPYL-ETHYL)-AMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 811-1124, PROTEIN KINASE DOMAIN; COMPND 5 SYNONYM: JANUS KINASE 3, JAK-3, LEUKOCYTE JANUS KINASE, L-JAK; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK3; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE-INHIBITOR COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.KUGLSTATTER,A.SHAO REVDAT 2 20-SEP-23 4I6Q 1 REMARK SEQADV REVDAT 1 16-OCT-13 4I6Q 0 JRNL AUTH S.JAIME-FIGUEROA,J.DE VICENTE,J.HERMANN,A.JAHANGIR,S.JIN, JRNL AUTH 2 A.KUGLSTATTER,S.M.LYNCH,J.MENKE,L.NIU,V.PATEL,A.SHAO,M.SOTH, JRNL AUTH 3 M.D.VU,C.YEE JRNL TITL DISCOVERY OF A SERIES OF NOVEL JRNL TITL 2 5H-PYRROLO[2,3-B]PYRAZINE-2-PHENYL ETHERS, AS POTENT JAK3 JRNL TITL 3 KINASE INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 23 2522 2013 JRNL REFN ISSN 0960-894X JRNL PMID 23541670 JRNL DOI 10.1016/J.BMCL.2013.03.015 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.54 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 25796 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1363 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1567 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 81.58 REMARK 3 BIN R VALUE (WORKING SET) : 0.2380 REMARK 3 BIN FREE R VALUE SET COUNT : 80 REMARK 3 BIN FREE R VALUE : 0.3300 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2221 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 92 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.52000 REMARK 3 B22 (A**2) : 0.10000 REMARK 3 B33 (A**2) : -1.62000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.140 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.140 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.097 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.431 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2311 ; 0.018 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3124 ; 1.872 ; 1.995 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 274 ; 5.594 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;34.911 ;22.804 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 393 ;15.704 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;17.759 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 331 ; 0.140 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1776 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 815 A 1102 REMARK 3 ORIGIN FOR THE GROUP (A): 3.0738 -13.7315 -14.9193 REMARK 3 T TENSOR REMARK 3 T11: 0.0946 T22: 0.0095 REMARK 3 T33: 0.1376 T12: 0.0123 REMARK 3 T13: 0.0178 T23: 0.0224 REMARK 3 L TENSOR REMARK 3 L11: 0.3563 L22: 0.4553 REMARK 3 L33: 1.2444 L12: -0.0376 REMARK 3 L13: -0.0917 L23: 0.4445 REMARK 3 S TENSOR REMARK 3 S11: 0.0239 S12: 0.0061 S13: 0.0154 REMARK 3 S21: -0.0582 S22: -0.0438 S23: -0.0365 REMARK 3 S31: 0.0424 S32: 0.0112 S33: 0.0199 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4I6Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-DEC-12. REMARK 100 THE DEPOSITION ID IS D_1000076373. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25796 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 41.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08400 REMARK 200 FOR THE DATA SET : 16.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.48300 REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: PDB ENTRY 4HVD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG3350, 0.1M MES, 0.2M MGCL, PH REMARK 280 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.43700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.63500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.82300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.63500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.43700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.82300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 811 REMARK 465 GLN A 812 REMARK 465 ASP A 813 REMARK 465 PRO A 814 REMARK 465 GLY A 892 REMARK 465 PRO A 893 REMARK 465 GLY A 894 REMARK 465 ARG A 895 REMARK 465 GLN A 896 REMARK 465 SER A 897 REMARK 465 GLY A 1039 REMARK 465 SER A 1040 REMARK 465 GLU A 1041 REMARK 465 ARG A 1042 REMARK 465 ASP A 1043 REMARK 465 ARG A 1103 REMARK 465 GLY A 1104 REMARK 465 CYS A 1105 REMARK 465 GLU A 1106 REMARK 465 THR A 1107 REMARK 465 HIS A 1108 REMARK 465 ALA A 1109 REMARK 465 PHE A 1110 REMARK 465 THR A 1111 REMARK 465 ALA A 1112 REMARK 465 HIS A 1113 REMARK 465 PRO A 1114 REMARK 465 GLU A 1115 REMARK 465 GLY A 1116 REMARK 465 LYS A 1117 REMARK 465 HIS A 1118 REMARK 465 HIS A 1119 REMARK 465 SER A 1120 REMARK 465 LEU A 1121 REMARK 465 SER A 1122 REMARK 465 PHE A 1123 REMARK 465 SER A 1124 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1364 O HOH A 1386 2.11 REMARK 500 O HOH A 1322 O HOH A 1381 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 940 CB - CG - CD1 ANGL. DEV. = 10.8 DEGREES REMARK 500 ARG A 953 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG A 953 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 ARG A1006 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 832 54.59 35.40 REMARK 500 ARG A 948 -11.61 80.12 REMARK 500 ALA A 966 -166.37 -122.27 REMARK 500 ASP A 967 80.25 58.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PHU A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1DT A 1202 DBREF 4I6Q A 811 1124 UNP P52333 JAK3_HUMAN 811 1124 SEQADV 4I6Q SER A 1040 UNP P52333 CYS 1040 ENGINEERED MUTATION SEQADV 4I6Q SER A 1048 UNP P52333 CYS 1048 ENGINEERED MUTATION SEQRES 1 A 314 CYS GLN ASP PRO THR ILE PHE GLU GLU ARG HIS LEU LYS SEQRES 2 A 314 TYR ILE SER GLN LEU GLY LYS GLY ASN PHE GLY SER VAL SEQRES 3 A 314 GLU LEU CYS ARG TYR ASP PRO LEU GLY ASP ASN THR GLY SEQRES 4 A 314 ALA LEU VAL ALA VAL LYS GLN LEU GLN HIS SER GLY PRO SEQRES 5 A 314 ASP GLN GLN ARG ASP PHE GLN ARG GLU ILE GLN ILE LEU SEQRES 6 A 314 LYS ALA LEU HIS SER ASP PHE ILE VAL LYS TYR ARG GLY SEQRES 7 A 314 VAL SER TYR GLY PRO GLY ARG GLN SER LEU ARG LEU VAL SEQRES 8 A 314 MET GLU TYR LEU PRO SER GLY CYS LEU ARG ASP PHE LEU SEQRES 9 A 314 GLN ARG HIS ARG ALA ARG LEU ASP ALA SER ARG LEU LEU SEQRES 10 A 314 LEU TYR SER SER GLN ILE CYS LYS GLY MET GLU TYR LEU SEQRES 11 A 314 GLY SER ARG ARG CYS VAL HIS ARG ASP LEU ALA ALA ARG SEQRES 12 A 314 ASN ILE LEU VAL GLU SER GLU ALA HIS VAL LYS ILE ALA SEQRES 13 A 314 ASP PHE GLY LEU ALA LYS LEU LEU PRO LEU ASP LYS ASP SEQRES 14 A 314 TYR TYR VAL VAL ARG GLU PRO GLY GLN SER PRO ILE PHE SEQRES 15 A 314 TRP TYR ALA PRO GLU SER LEU SER ASP ASN ILE PHE SER SEQRES 16 A 314 ARG GLN SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR SEQRES 17 A 314 GLU LEU PHE THR TYR CYS ASP LYS SER CYS SER PRO SER SEQRES 18 A 314 ALA GLU PHE LEU ARG MET MET GLY SER GLU ARG ASP VAL SEQRES 19 A 314 PRO ALA LEU SER ARG LEU LEU GLU LEU LEU GLU GLU GLY SEQRES 20 A 314 GLN ARG LEU PRO ALA PRO PRO ALA CYS PRO ALA GLU VAL SEQRES 21 A 314 HIS GLU LEU MET LYS LEU CYS TRP ALA PRO SER PRO GLN SEQRES 22 A 314 ASP ARG PRO SER PHE SER ALA LEU GLY PRO GLN LEU ASP SEQRES 23 A 314 MET LEU TRP SER GLY SER ARG GLY CYS GLU THR HIS ALA SEQRES 24 A 314 PHE THR ALA HIS PRO GLU GLY LYS HIS HIS SER LEU SER SEQRES 25 A 314 PHE SER HET PHU A1201 10 HET 1DT A1202 24 HETNAM PHU 1-PHENYLUREA HETNAM 1DT N-[(1S)-1-CYCLOPROPYLETHYL]-2-PHENOXY-5H-PYRROLO[2,3- HETNAM 2 1DT B]PYRAZINE-7-CARBOXAMIDE HETSYN PHU PHENYLUREA FORMUL 2 PHU C7 H8 N2 O FORMUL 3 1DT C18 H18 N4 O2 FORMUL 4 HOH *92(H2 O) HELIX 1 1 GLU A 818 ARG A 820 5 3 HELIX 2 2 GLY A 861 ALA A 877 1 17 HELIX 3 3 CYS A 909 ARG A 918 1 10 HELIX 4 4 ALA A 919 LEU A 921 5 3 HELIX 5 5 ASP A 922 ARG A 943 1 22 HELIX 6 6 ALA A 951 ARG A 953 5 3 HELIX 7 7 PRO A 990 TYR A 994 5 5 HELIX 8 8 ALA A 995 ASN A 1002 1 8 HELIX 9 9 ARG A 1006 THR A 1022 1 17 HELIX 10 10 ASP A 1025 CYS A 1028 5 4 HELIX 11 11 SER A 1029 MET A 1038 1 10 HELIX 12 12 PRO A 1045 GLU A 1056 1 12 HELIX 13 13 PRO A 1067 TRP A 1078 1 12 HELIX 14 14 SER A 1081 ARG A 1085 5 5 HELIX 15 15 SER A 1087 GLY A 1101 1 15 SHEET 1 A 5 LEU A 822 GLY A 831 0 SHEET 2 A 5 GLY A 834 TYR A 841 -1 O VAL A 836 N LEU A 828 SHEET 3 A 5 LEU A 851 LEU A 857 -1 O VAL A 854 N GLU A 837 SHEET 4 A 5 ARG A 899 GLU A 903 -1 O LEU A 900 N LYS A 855 SHEET 5 A 5 TYR A 886 SER A 890 -1 N ARG A 887 O VAL A 901 SHEET 1 B 2 CYS A 945 VAL A 946 0 SHEET 2 B 2 LYS A 972 LEU A 973 -1 O LYS A 972 N VAL A 946 SHEET 1 C 2 ILE A 955 SER A 959 0 SHEET 2 C 2 HIS A 962 ILE A 965 -1 O LYS A 964 N LEU A 956 SHEET 1 D 2 TYR A 980 VAL A 982 0 SHEET 2 D 2 ILE A1003 SER A1005 -1 O PHE A1004 N TYR A 981 SITE 1 AC1 7 PHE A 992 TRP A1011 PRO A1030 MET A1037 SITE 2 AC1 7 ARG A1059 LEU A1060 TRP A1078 SITE 1 AC2 12 LEU A 828 GLY A 829 VAL A 836 ALA A 853 SITE 2 AC2 12 GLU A 903 TYR A 904 LEU A 905 GLY A 908 SITE 3 AC2 12 ARG A 953 LEU A 956 ALA A 966 HOH A1347 CRYST1 46.874 75.646 89.270 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021334 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013219 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011202 0.00000